Candid Therapeutics

Advertisement

cGxPJobs Banner

UCB to Acquire Candid Therapeutics in $2.2B Immunology Deal

SAN DIEGO, CALIFORNIA, May 03, 2026 UCB has announced a definitive agreement to acquire Candid Therapeutics in a transaction...

By cGxPwire Editor
May 5, 2026

Read More

Advertisement

cGxPJobs

Directory